Frederick Oni, MD
Gastroenterology · Warner Robins, GANPI 1174553226
Payments from drug & device makers
Across 114 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$365
- Ardelyx, Inc.$185
- Takeda Pharmaceuticals U.S.A., Inc.$173
- Phathom Pharmaceuticals, Inc.$149
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$149
- Merck$139
- plus $975 from 14 others
What the payments were for
- Food & beverage$2,136100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $365 |
| Ardelyx, Inc. | 9 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $173 |
| Phathom Pharmaceuticals, Inc. | 9 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $149 |
| Merck | 9 | $139 |
| Redhill Biopharma Inc. | 6 | $122 |
| Johnson & Johnson | 6 | $116 |
| Gilead | 5 | $114 |
| Nestle Healthcare Nutrition Inc. | 5 | $97 |
| QOL Medical, LLC | 3 | $81 |
| Madrigal Pharmaceuticals | 3 | $78 |
| Ironwood Pharmaceuticals, Inc | 5 | $75 |
| Intercept Pharmaceuticals, Inc. | 3 | $70 |
| Braintree Laboratories, Inc. | 3 | $53 |
| Regeneron Healthcare Solutions, Inc. | 3 | $50 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Pfizer | 2 | $35 |
| Evoke Pharma, Inc. | 2 | $27 |
| Vivus LLC | 1 | $23 |
How this compares
$2,136 in reported general payments places this provider in the 35th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 12 | $8,202 |
| Mesalamine ErMesalamine | 14 | $4,765 |
| Sucralfate | 30 | $4,277 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 147 | $2,131 |
| Ondansetron OdtOndansetron | 20 | $1,823 |
| Famotidine | 67 | $870 |
| Esomeprazole Magnesium | 22 | $766 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 46 | $715 |
| Azathioprine | 12 | $593 |
| Omeprazole | 36 | $562 |
| Pantoprazole Sodium | 58 | $533 |
| Dicyclomine Hcl | 18 | $335 |
| Tenofovir Disoproxil Fumarate | 12 | $320 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Warner Robins
- Douglas WolfAtlanta$6.4M
- Aasim SheikhMarietta$6M
- Shahriar SedghiMacon$5.4M
- Jeffrey WilliamsAthens$2.5M
- Michael GalambosAtlanta$1.8M
- Nitin GuptaAtlanta$1.7M
- Bruce SalzbergSuwanee$1.4M
- Heba IskandarAtlanta$978K
- David RausherDecatur$907K
- Florence Hosseini AsliniaHiram$885K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.